FDA Adverse Event Injury Summary report: N

ACRYSOF IQ NATURAL SINGLEPIECE IOL

MDR report key: 9864962 · Received March 23, 2020

Report

Report Number
1119421-2020-00486
Event Type
Injury
Date Received
March 23, 2020
Report Date
March 23, 2020
Manufacturer
ALCON RESEARCH, LLC - HUNTINGTON
Product Code
HQL
PMA / PMN Number
P930014
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SC, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

EVALUATION SUMMARY: COMPLAINT HISTORY AND PRODUCT HISTORY RECORD COULD NOT BE REVIEWED BECAUSE THE REPORTING FACILITY DID NOT PROVIDE A VALID LOT NUMBER OR ANY IDENTIFICATION TRACEABLE TO THE MANUFACTURING DOCUMENTATION. ROOT CAUSE HAS NOT BEEN IDENTIFIED. (B)(4).

Description of Event or Problem · 1

A CONSUMER REPORTED THAT FOLLOWING A CATARACT EXTRACTION WITH INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, SHE SEES A SPACE SHIP LIKE IMAGE, HER VISION IS BLURRY, BUT BETTER SINCE YAG LASER. ADDITIONAL INFORMATION WAS PROVIDED BY A PHYSICIAN, THAT HE PERFORMED A YAG ON THIS PATIENT IN (B)(6). HER CATARACT SURGERIES WERE DONE BY A DIFFERENT PHYSICIAN IN 2012. THERE ARE NO DOCUMENTED VISUAL PROBLEMS OR DYSPHOTOPSIAS AT HER (B)(6) 2019 EXAM WITH A DIFFERENT DOCTOR (HER ONLY EXAM OF RECORD IN THE ELECTRONIC MEDICAL RECORD PRIOR TO THIS YEAR) AND SHE SAID SHE ONLY USED GLASSES FOR TINY PRINT. ON (B)(6) 2020, SHE HAD 20/100 VISION SECONDARY TO 4+ PCO, AND A CAPSULOTOMY WAS PERFORMED. HER UCVA WAS 20/25 ON (B)(6) 2020. SHE WAS OFFERED A ONE WEEK FOLLOW UP IF SHE HAD ANY PROBLEMS OR NEEDED AN UPDATED PRESCRIPTION. SHE DID NOT RETURN AND HAS HAD NO DOCUMENTED CORRESPONDENCE WITH OUR OFFICE IN ELECTRONIC MEDICAL RECORDS. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS PATIENT. THIS REPORT IS ASSOCIATED WITH THE LEFT EYE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
332989 ACRYSOF IQ NATURAL SINGLEPIECE IOL INTRAOCULAR LENS HQL ALCON RESEARCH, LLC - HUNTINGTON SN60WF ASKU

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention